+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of high dose intravenous immunoglobulins in dermatology



Use of high dose intravenous immunoglobulins in dermatology



Journal der Deutschen Dermatologischen Gesellschaft 8(5): 386




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056798412

Download citation: RISBibTeXText

PMID: 20537010

DOI: 10.1111/j.1610-0387.2010.07379.x


Related references

The use of high dose intravenous immunoglobulins in dermatology. Journal der Deutschen Dermatologischen Gesellschaft 1(3): 183-190, 2003

Use of high-dose immunoglobulins in dermatology. Journal der Deutschen Dermatologischen Gesellschaft 7(9): 806-812, 2009

High-dose intravenous immunoglobulins. Journal of Perinatal Medicine 24(5): 539, 1996

Use of high-dose intravenous immunoglobulins in pediatric hematology. La Pediatria Medica e Chirurgica 16(1): 37-41, 1994

High-dose intravenous immunoglobulins in neurocritical care. Intensivmedizin und Notfallmedizin 32(8): 642-650, 1995

Side effects of high-dose intravenous immunoglobulins. Clinical Neuropharmacology 20(5): 385-393, 1997

Guidelines on the use of high-dose intravenous immunoglobulin in dermatology. European Journal of Dermatology 19(1): 90-98, 2009

Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases. Archives of Neurology 56(6): 661-663, 1999

Aseptic meningitis during treatment with high-dose intravenous immunoglobulins. Presse Medicale 25(13): 643, 1996

Immunomodulation in myasthenia gravis by high dose intravenous 7 s immunoglobulins. Drachman, D B (Ed ) Annals Of The New York Academy Of Sciences, Vol 505 Myasthenia Gravis: Biology And Treatment; Seventh International Conference, New York, New York, Usa, March 4-7, 1986 Xvii+914p The New York Academy Of Sciences: New York, New York, Usa Illus 828-831, 1987

Known and potential risks related to the use of high dose intravenous immunoglobulins. Annales de Dermatologie et de Venereologie 124(5): 381-383, 1997

Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins. Springer Seminars in Immunopathology 23(4): 447-457, 2001

High-dose intravenous immunoglobulins Adverse reactions in 125 patients with ITP. British Journal of Haematology 102(1): 363, 1998

The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome. Anaesthesia 47(3): 220-222, 1992

High dose intravenous immunoglobulins in guillain barre syndrome. Revue Neurologique (Paris) 145(10): 731-732, 1989